First Shots Given in Trial of Moderna’s mRNA-Based HIV Vaccine
TUESDAY, Feb. 1, 2022 (HealthDay News) — Vaccinations have been given to the first volunteers in a Phase 1 trial of Moderna’s experimental HIV vaccine, the company has announced. The vaccine uses mRNA technology — similar to that utilized in breakthrough COVID vaccines — to deliver HIV-specific antigens that couldContinue Reading